AZD1656 in Diabetic Patients Hospitalised With Suspected or Confirmed COVID-19
Status:
Completed
Trial end date:
2021-05-12
Target enrollment:
Participant gender:
Summary
The ARCADIA Trial is a randomised, double-blind, placebo-controlled clinical trial to assess
the safety and efficacy of AZD1656 in patients with either Type 1 or Type 2 diabetes,
hospitalised with COVID-19.